ARCHIVES

“With resources now constrained, the ability of NCI to be responsive to its constituencies has been compromised.”

This article is from The Cancer Letter archive.

Vol. 21 No. 27 | July 7, 1995

Download PDF Visit The Full Archive

Related Articles

SEC Investigating Bristol-Myers’ Sales Statements

July 12, 2002

Obituary: Edwin Fisher, NSABP Pathologist.

April 4, 2008

Tasigna Shows Benefit Over Gleevec In Phase III Study for Ph+ CML In Chronic Phase

December 31, 2010

Britain’s Cancer Czar Begins Examination of Risks and Benefits of Mammography

October 28, 2011

In Brief: Michael Boyd Named New DTP Director; Saunders Retires; Michael Friedman New Chief Of CIB

October 7, 1983

Columnist, Kushner, Four Others Names To NCAB

May 9, 1980